Patrik Ernfors is head of Division of Molecular Neurobiology and Professor of Tissue biology at Karolinska Institutet, Sweden. He received a PhD in neuroscience at Karolinska Institute and completed postdoctoral training at the Whitehead Institute, MIT, USA. He returned to a faculty position at Karolinska Institute in 1993. His research group studies the neural pathways in the somatosensory system, that underly our ability to sense touch, temperature, itch and pain. Ernfors laboratory combines molecular, computational and systems neuroscience to understand the key cell types and their organisation and applies this knowledge to provide insights into what causes chronic pain. His detailed classification of neurons has proven foundational for insights into how we detect environmental stimuli and their contribution to how we sense the world within and around us. He has shown a remarkable degree of conservation somatosensory cell types and their spatial organization that has enabled translation into humans of knowledge gained from decades of studies on model organisms. This has provided vital new insights into the human somatosensory system in health and disease.

Dr. Margarita Calvo Bascuñán is an Associate Professor at the Pontificia Universidad Católica de Chile and a leading clinician‑scientist in neuropathic pain research. Her work integrates molecular biology, preclinical models, and psychophysical studies to investigate mechanisms of small‑fiber neuropathy, dermatological pain conditions such as recessive dystrophic epidermolysis bullosa, and common neuropathies including diabetic and chemotherapy‑induced neuropathy. 

She earned her MD from UC Chile, a Master’s in Pain Management and a PhD in Neuroscience from King’s College London, and later a Master’s in Peripheral Neuropathies from the University of Milan. She completed a postdoctoral fellowship at King’s College London and has held visiting and honorary research positions in Oxford and London. 

Dr. Calvo directs the Neuropathic Pain Laboratory at UC Chile, advancing translational pain science, and she serves as an IASP Councilor and member of the NeuPSIG Secretary.

Ed completed his PhD in Pharmacology at the University of Cambridge under the supervision of Prof. Peter McNaughton, where his research focused on elucidating the role of HCN2 ion channels in acute and chronic pain. After completing his PhD, he undertook postdoctoral positions in the labs of Prof. Fiona Gribble, characterizing novel SCN9A mutations linked to congenital pain phenotypes, and Prof. John Wood, where he developed innovative in vivo imaging techniques to monitor sensory neuron function.

 After his postdoctoral training, Ed transitioned to industry by joining GlaxoSmithKline’s Immunology Research Unit. There, he led the translational pain research strategy for multiple neuroimmune programs, including those targeting CCL17 and GM-CSF. Subsequently, he moved to AstraZeneca’s Translational Medicine group, where he was responsible for directing translational strategies across several neuroscience indications including pain, neurodegeneration, and migraine, spanning early preclinical to Phase 2 development stages.

 In 2025, Ed joined Grünenthal where he currently leads translational strategy for several preclinical and clinical programs to support the development of novel, non-opioid treatments for chronic pain.

Mukesh Pokharel, BPT (2017) and MPT (MSK & Sports, 2025) from Kathmandu University, is a physiotherapist and researcher from Nepal dedicated to improving physiotherapy access and care for underprivileged populations. He worked at Annapurna Neurological Hospital (ANIAS) from 2017 to 2022, gaining extensive clinical experience. His research is primarily focused on back pain, particularly chronic non-specific low back pain, including the development of culturally tailored pain-related questionnaires, and explores the biopsychosocial model, fear-avoidance beliefs, and pain education. He is currently involved with the Chaudhary Foundation as an advisory consultant for its prosthetic centre and health-related projects. Mukesh has presented his work at national and international conferences and continues to promote evidence-based, contextually relevant pain care in Nepal.

Pascal Röderer is a postdoctoral researcher at RWTH Aachen University in the lab of Angelika Lampert. He studied Biochemistry at Ruhr University Bochum, specializing in neuroscience, and was first introduced to induced pluripotent stem cell (iPSC) technology during a research stay at the Icahn School of Medicine at Mount Sinai in New York City. He subsequently completed his PhD at the University of Bonn, developing stem cell-derived models of the peripheral nervous system with a focus on sensory neurons.

His current research centers on human sensory neuron development, neuron-glia interactions, and disease modeling, with an additional interest in the functional biology of voltage-gated sodium channels. In addition to his scientific work, he is actively engaged in the German Stem Cell Network (GSCN), NeuPSIG, and the task force for the IASP Global Year on Neuropathic Pain 2026.

Dr. Nahman-Averbuch is an Associate Professor at the Washington University Pain Center and the Division of Clinical and Translational Research at the Department of Anesthesiology, Washington University School of Medicine. Dr. Nahman-Averbuch has a Ph.D. in Medical Sciences from the Technion-Israel Institute of Technology. During her Ph.D, she worked with Dr. David Yarnitsky and specialized in pain modulation mechanisms in adults with chronic pain. Dr. Nahman-Averbuch completed her post-doctoral fellowship at Cincinnati Children’s Hospital with Dr. Robert Coghill where she studied the neural changes in pediatric patients with chronic pain and after interventions such as cognitive-behavioral therapy. In her Pain Across the Lifespan (PAL) lab, she focuses on studying the impact of sex hormones on pain specifically in adults and adolescents with migraine, endometriosis and arthritis. Dr. Nahman-Averbuch is involved with IASP and USASP and seeks to promote early career programs and is the past president for the IASP Early Career Network.  

Dr. Rachael Coakley is pediatric pain psychologist in the Department of Anesthesia, Critical Care and Pain Medicine at Boston Children’s Hospital, where she serves as the Director of Clinical Innovation and Outreach in Pain Medicine. Additionally, she is the Founder and Director of The Comfort Ability Program, an internationally disseminated program that empowers youth living with chronic pain and functional symptoms and their families through evidence-based intervention, education, and compassionate support.

Dr. Coakley is an Associate Professor of Psychology at Harvard Medical School and holds national and international leadership positions. Her research focuses on translational and implementation science as it relates to the development and dissemination of evidence-based psychological intervention. She has been honored with several awards for her program development work, including the American Psychological Association’s National Carolyn Schroeder Award for outstanding clinical practice. Outside her academic work, Dr. Coakley enjoys lecturing and writing to educate patients, parents, and providers about chronic pain. Her book, "When Your Child Hurts: Effective Strategies to Increase Comfort, Reduce Stress and Break the Cycle of Chronic Pain" won a national book award for a best parenting book of the year. Her writing is also featured in a Psychology Today column, the Washington Post, and other publications.

Natisha Nabbijohn, PhD, is a Psychologist in Supervised Practice at McMaster Children’s Hospital, where she works in the Gender Diversity and Adolescent Medicine programs. She recently completed her PhD in Clinical Child and Adolescent Psychology at the University of Guelph under the supervision of Dr. Meghan McMurtry, successfully defending her dissertation in August 2026.

Natisha’s research focuses on advancing theory and methods for understanding coping in the context of pediatric chronic pain, with a focus on better capturing the diverse needs and lived experiences of youth. During her master’s training, she conducted a scoping review of coping in pediatric chronic pain, identifying gaps in how coping has been conceptualized and measured. This work informed the development of the Integrative Model of the Coping Process as applied to pediatric chronic pain. Her doctoral research used a multimethod approach to further evaluate and develop this model, examining adolescents’ perspectives on coping, the role of social identity, and differences in coping across contexts and social groups, including gender and socioeconomic status. Her graduate research was supported by scholarships from the Canadian Institutes of Health Research (CIHR) and the Ontario Graduate Scholarship (OGS).

Natisha has been actively involved in the pediatric pain community through Pain in Child Health (PICH) and the Society of Pediatric Pain’s Gender and Pain Special Interest Group. Her interest in the intersection of social identity and youth well-being began during her undergraduate and master’s training at the University of Toronto, where she examined biological, psychological, and social factors related to the well-being of gender minority youth. She now brings together these areas of expertise in her clinical work, supporting youth with diverse gender identities and experiences of chronic illness and pain.

Nicole MacKenzie is a Postdoctoral Fellow at the Hospital for Sick Children under the supervision of Dr. Jennifer Stinson, and a Psychologist in Supervised Practice in the SickKids Chronic Pain Clinic. She holds a PhD in Clinical Psychology from Dalhousie University. Her research focuses on implementation science and practice within pediatric pain, with particular interests in shared decision making and interest-holder engagement in knowledge mobilization activities. Nicole takes a patient-centred lens to all of her research and her work aims to improve how people with lived experience are included in processes to put knowledge into action.